Key Takeaways
- • Warburg Pincus and Lendlease jointly acquired a S$1.6 billion (approximately $1.23 billion USD) portfolio of industrial and life sciences assets in Singapore, marking one of the largest private industrial asset transactions in the Singapore market.
- • The acquisition represents the first transaction for the JV platform since its official launch on 31 July 2024, immediately establishing the venture as a market-leading life sciences and R&D real estate platform in Asia Pacific with over S$2 billion in assets under management.
- • The portfolio comprises 4.5 million square feet of gross floor area across high-quality business parks and specialist facilities in established precincts, with tenants including blue-chip companies in life sciences, technology, advanced manufacturing, and logistics sectors.
- • Assets were acquired from entities associated with Blackstone and Soilbuild Group Holdings Ltd. Executive Chairman Lim Chap Huat, consolidating Warburg Pincus and Lendlease's positioning as top industrial asset owners in Singapore.
- • The transaction underscores institutional investor appetite for Asia Pacific life sciences and R&D real estate, with the JV platform positioned to capitalize on the region's rapidly expanding sector.
Summary
Warburg Pincus and Lendlease have completed a S$1.6 billion acquisition of a portfolio of Singapore-based industrial and life sciences assets, announced on 27 August 2024. The transaction, executed through their jointly established platform alongside the managed investment vehicle LINO, represents one of the largest private industrial asset transactions in Singapore's market. The assets were sourced from entities associated with Blackstone and Soilbuild Group Holdings Ltd. Executive Chairman Lim Chap Huat.
The acquisition marks the inaugural transaction for the Warburg Pincus-Lendlease JV platform, which was officially launched on 31 July 2024 with a strategic mandate to focus on life sciences and R&D real estate across the Asia Pacific region. The portfolio comprises approximately 4.5 million square feet of gross floor area distributed across high-quality business parks and specialized facilities located within established designated precincts across Singapore. Tenants span blue-chip companies operating in life sciences, technology, advanced manufacturing, and logistics sectors, providing diversified cash flow exposure across high-growth industry verticals.
With this acquisition, the JV platform has rapidly established itself as the market-leading life sciences and R&D real estate operator in Asia Pacific, commanding over S$2 billion in assets under management. Takashi Murata, Managing Director and Co-Head of Asia Real Estate at Warburg Pincus, highlighted the strategic significance, stating the portfolio "gives us immediate scale in the tightly held Singapore market, cementing our position as one of the top industrial asset owners in Singapore." Justin Gabbani, CEO of Investment Management at Lendlease, emphasized the transaction's alignment with the platform's commitment to the region's "rapidly expanding life sciences and R&D real estate market in Asia Pacific."
The timing and scale of this acquisition reflect sustained institutional capital flows into Asia Pacific life sciences and specialized industrial real estate, driven by secular trends including pharmaceutical manufacturing diversification, biotech expansion, and advanced technology manufacturing. The transaction positions the Warburg Pincus-Lendlease platform as a consolidator in a fragmented Singapore industrial real estate market, with first-mover advantage in the specialist life sciences and R&D asset class during a period of significant sector growth.
The acquisition marks the inaugural transaction for the Warburg Pincus-Lendlease JV platform, which was officially launched on 31 July 2024 with a strategic mandate to focus on life sciences and R&D real estate across the Asia Pacific region. The portfolio comprises approximately 4.5 million square feet of gross floor area distributed across high-quality business parks and specialized facilities located within established designated precincts across Singapore. Tenants span blue-chip companies operating in life sciences, technology, advanced manufacturing, and logistics sectors, providing diversified cash flow exposure across high-growth industry verticals.
With this acquisition, the JV platform has rapidly established itself as the market-leading life sciences and R&D real estate operator in Asia Pacific, commanding over S$2 billion in assets under management. Takashi Murata, Managing Director and Co-Head of Asia Real Estate at Warburg Pincus, highlighted the strategic significance, stating the portfolio "gives us immediate scale in the tightly held Singapore market, cementing our position as one of the top industrial asset owners in Singapore." Justin Gabbani, CEO of Investment Management at Lendlease, emphasized the transaction's alignment with the platform's commitment to the region's "rapidly expanding life sciences and R&D real estate market in Asia Pacific."
The timing and scale of this acquisition reflect sustained institutional capital flows into Asia Pacific life sciences and specialized industrial real estate, driven by secular trends including pharmaceutical manufacturing diversification, biotech expansion, and advanced technology manufacturing. The transaction positions the Warburg Pincus-Lendlease platform as a consolidator in a fragmented Singapore industrial real estate market, with first-mover advantage in the specialist life sciences and R&D asset class during a period of significant sector growth.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.